Neuroscientific Biopharmaceuticals Ltd (NSB.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Operating Expenses | 2,009 | 2,057 | 6,124 | 10,504 | 4,224 |
| Operating Income | -2,009 | -2,057 | -6,124 | -10,504 | -4,224 |
| Interest Expense | 2 | 10 | 5 | N/A | 0 |
| Other Income | 166 | 2,391 | 5,060 | 68 | 1,046 |
| Pre-tax Income | -1,846 | 324 | -1,069 | -10,435 | -3,178 |
| Net Income Continuous | -1,846 | 324 | -1,069 | -10,435 | -3,178 |
| Net Income | $-1,846 | $324 | $-1,069 | $-10,435 | $-3,178 |
| EPS Basic Total Ops | -0.01 | 0.00 | -0.01 | -0.07 | -0.02 |
| EPS Basic Continuous Ops | -0.01 | 0.00 | -0.01 | -0.07 | -0.02 |
| EPS Diluted Total Ops | -0.01 | 0.00 | -0.01 | -0.07 | -0.02 |
| EPS Diluted Continuous Ops | -0.01 | 0.00 | -0.01 | -0.07 | -0.02 |
| EBITDA(a) | $-1,750 | $426 | $-1,006 | $-10,439 | $-3,116 |